首页 › 基金 › SPHERA FUNDS MANAGEMENT LTD. › CBIO
SPHERA FUNDS MANAGEMENT LTD. 对 CBIO 的持仓历史
CRESCENT BIOPHARMA INC. · 医疗保健
SPHERA FUNDS MANAGEMENT LTD. 在 Q3 2026 的 13F 申报中披露持有 CBIO(CRESCENT BIOPHARMA INC.)279,718 股,市值约 US$4.1M,约占其申报组合的 0.63%,在其申报持仓中市值排名第 48 位。 SPHERA FUNDS MANAGEMENT LTD. 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
SPHERA FUNDS MANAGEMENT LTD. 对 CBIO 的持仓演变
SPHERA FUNDS MANAGEMENT LTD. 于 Q3 2026 首次披露 CBIO 持仓:279,718 股(约 US$4.1M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 279.72K | $4.08M | 新进 |
关于 CBIO 与 13F 数据
CBIO(CRESCENT BIOPHARMA INC.)属于医疗保健行业。我们追踪的基金中还有 66 只申报持有 CBIO,申报仓位最大的包括:Fairmount Funds Management LLC (US$52.5M), BVF INC/IL (US$45.1M), Vestal Point Capital, LP (US$43.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CBIO 的基金
- Fairmount Funds Management LLC 3.60M 股 · $52.54M · Q3 2026
- BVF INC/IL 3.09M 股 · $45.14M · Q3 2026
- Vestal Point Capital, LP 3.00M 股 · $43.77M · Q3 2026
- Venrock Adviser, LLC 2.13M 股 · $31.13M · Q3 2026
- FCPM III SERVICES B.V. 2.02M 股 · $29.51M · Q3 2026
- Opaleye Management Inc. 1.32M 股 · $23.75M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.16M 股 · $16.92M · Q3 2026
- Logos Global Management LP 850.00K 股 · $12.40M · Q3 2026
- NEXTBio Capital Management LP 372.86K 股 · $5.44M · Q3 2026
- Remedium Capital Partners, LLC 361.25K 股 · $5.27M · Q3 2026
- Squadron Capital Management LLC 350.00K 股 · $5.11M · Q3 2026
- Boxer Capital Management, LLC 226.84K 股 · $3.31M · Q3 2026
更多关于 SPHERA FUNDS MANAGEMENT LTD.
常见问题
How long has SPHERA FUNDS MANAGEMENT LTD. held CBIO?
SPHERA FUNDS MANAGEMENT LTD. has disclosed CBIO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in CBIO?
As of Q3 2026, SPHERA FUNDS MANAGEMENT LTD. holds 279.72K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $4.08M, representing 0.63% of its reported portfolio and ranking #48.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling CBIO?
In the latest 13F filing (Q3 2026), SPHERA FUNDS MANAGEMENT LTD. newly opened its position in CBIO.
Which other funds hold CBIO?
Other major institutional holders of CBIO include Fairmount Funds Management LLC, BVF INC/IL, Vestal Point Capital, LP, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.